(Q31704898)

3 July 2017

Sex differences in nevirapine rash (English)

1 reference

3 July 2017

1 reference

2

1 reference

3 July 2017

Bersoff-Matcha SJ

1

1 reference

3 July 2017

Aberg JA

3

1 reference

3 July 2017

van Der Horst C

4

1 reference

3 July 2017

Hamrick Jr HJ

5

1 reference

3 July 2017

Powderly WG

6

1 reference

3 July 2017

Mundy LM

7

1 reference

3 July 2017

language of work or name

English

0 references

publication date

13 December 2000

1 reference

Clinical Infectious Diseases

3 July 2017

1 reference

3 July 2017

32

1 reference

3 July 2017

1

1 reference

3 July 2017

124-129

1 reference

Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P

3 July 2017

1 reference

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

21 January 2018

1 reference

Pharmacokinetics of nevirapine: initial single-rising-dose study in humans

21 January 2018

1 reference

Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005.

21 January 2018

1 reference

Blood-brain barrier properties of human immunodeficiency virus antiretrovirals

21 January 2018

1 reference

Binomial regression in GLIM: estimating risk ratios and risk differences

21 January 2018

1 reference

Gender differences in adverse drug reactions.

21 January 2018

1 reference

Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program

21 January 2018

1 reference

Coumarin-induced skin necrosis. Incidence, mechanisms, management and avoidance

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/317536

1 reference

3 July 2017

1 reference